BIRC5 and brain cancer: RAW 264.7 cells treated with DCE showed reduced expressions of oncogenic proteins, that is, deleted in malignant brain tumors 1 (DMBT1, 95%), 14-3-3 (89.9%), and survivin (96.4%), compared to non-treated controls.